NAUREEN JAFFRI: Open Payments
NPI 1487605333 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 41 payments from 11 companies in 2025. Trend: 2023 $1,064 · 2024 $1,085 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $258 |
| Neurocrine BioSciences, Inc. | 9 | $249 |
| Vanda Pharmaceuticals Inc. | 9 | $233 |
| Lundbeck LLC | 4 | $95 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Alkermes, Inc. | 1 | $29 |
| Biogen, Inc. | 1 | $28 |
Products named: CAPLYTA, INGREZZA, FANAPT, REXULTI, Auvelity, AUSTEDO XR, HETLIOZ, SPRAVATO.
Industry payments across NY — which companies pay providers there.
